Loading clinical trials...
Loading clinical trials...
Ozanimod Pregnancy Safety Study in Pregnant Women With Ulcerative Colitis and Their Offspring
Conditions
Interventions
Ozanimod
Conventional therapy
+1 more
Locations
1
United States
OptumInsight Life Sciences Inc
Eden Prairie, Minnesota, United States
Start Date
August 26, 2024
Primary Completion Date
May 31, 2031
Completion Date
June 30, 2032
Last Updated
October 1, 2024
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions